Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).
Katz, B.A., Luong, C., Ho, J.D., Somoza, J.R., Gjerstad, E., Tang, J., Williams, S.R., Verner, E., Mackman, R.L., Young, W.B., Sprengeler, P.A., Chan, H., Mortara, K., Janc, J.W., McGrath, M.E.(2004) J Mol Biol 344: 527-547
- PubMed: 15522303 
- DOI: 10.1016/j.jmb.2004.09.032
- Primary Citation of Related Structures:  
1O5G, 1O5F, 1O5E, 1O5D, 1O5C, 1O5B, 1O5A - PubMed Abstract: 
A site-directed mutant of the serine protease urokinase-type plasminogen activator (uPA), was produced to assess the contribution of the Ser190 side-chain to the affinity and selectivity of lead uPA inhibitors in the absence of other differences present in comparisons of natural proteases ...